bioresearch-filters-purificationFeaturedArticles

  1. 2025 Cell Therapy Outlook From BPI West 3/31/2025

    Bioprocess Online and Cell & Gene spoke with Takeda’s Amy Shaw at BPI West to discuss the industry and her key takeaways from the conference.

  2. 90 Years Of Border Blasting: A Look At The Fascinating History Of Border Radio 12/17/2024

    Mexican border radio, also known as border blasters, emerged in the 1930s and significantly shaped American and Mexican popular culture for decades.

  3. Tyra Crystallizing The First Oral FGFR3 Therapy For Achondroplasia 9/30/2025

    Tyra Biosciences is using its SNÅP drug discovery platform to develop dabogratinib, the first oral FGFR3-selective therapy for achondroplasia, currently recruiting patients in Phase 2 trials.

  4. RF Integration Game-Changers: Multi-Band MMICs, Active Phased Arrays, And 6G 7/11/2025

    Advances in MMIC and RFIC technologies are driving 5G/6G and satellite communications with multi-band support, digital beamforming, and emerging sub-THz frequencies, while addressing key challenges in linearity, thermal management, and transistor technology.

  5. Hyperspectral Imaging And Agriculture (Or How To Pick The Perfect Pepper) 1/23/2024

    A method of classifying the ripeness of peppers using hyperspectral imaging was in the news recently but the technology has been a part of the agriculture industry for decades. Learn more about this non-invasive technique that can determine a pepper's firmness and a whole lot more.

  6. Fabled Route-Scouters Riding AI Applications 11/18/2024

    Route scouting professionals – self-effacing hunters of small-molecule simplicity, searching for efficient pathways to commercial success, fearless in pointing out risks, and at times, dead ends. Today they face mounting challenges. Can artificial intelligence (AI) bring more clairvoyance to these battered scientists? “Absolutely,” says Dr. Jürgen Swienty-Busch of Elsevier.

  7. FCPA Enforcement Paused At DOJ, But Biopharma Shouldn't Pause Compliance 2/21/2025

    Criminal enforcement of the Foreign Corrupt Practices Act was paused on February 10 by a Trump administration executive order. That doesn't mean biopharmaceutical companies can backslide on compliance in global markets.

  8. Cell & Gene Therapy Outsourcing's New Paradigm 10/7/2025

    The industry has flipped from scarcity to surplus, and sponsors now have leverage to set terms, not take numbers.

  9. Insights From 250+ Regulatory Inspections 6/10/2025

    Elisabeth George, who has led more than 250 FDA inspections, shares practical advice for hosting audits — including preparation tips, team coordination, live documentation, and knowing exactly when to speak.

  10. For Gilead, Sustainability Is More Than A PR Effort 2/14/2025

    Gilead's chief sustainability officer and SVP of operations, Joydeep Ganguly, explains the company's cultural focus on sustainability and how it influences everything from R&D to manufacturing.